Litcius/Paper detail

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

Eric Lawitz, Bal Raj Bhandari, Peter Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen‐Chieh Chuang, Ryan S. Huss, Chuhan Chung, Robert P. Myers, Rohit Loomba

2022Clinical Gastroenterology and Hepatology54 citationsDOIOpen Access PDF

Topics & Concepts

MedicineFenofibrateInterquartile rangeInternal medicineGastroenterologyHypertriglyceridemiaAdverse effectTriglycerideEndocrinologyCholesterolLiver Disease Diagnosis and TreatmentPancreatitis Pathology and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat | Litcius